...
首页> 外文期刊>Contemporary clinical trials >I-CAN SLEEP: rationale and design of a non-inferiority RCT of Mindfulness-based Stress Reduction and Cognitive Behavioral Therapy for the treatment of Insomnia in CANcer survivors.
【24h】

I-CAN SLEEP: rationale and design of a non-inferiority RCT of Mindfulness-based Stress Reduction and Cognitive Behavioral Therapy for the treatment of Insomnia in CANcer survivors.

机译:I-CAN SLEEP:基于正念减压和认知行为疗法的非劣效RCT的原理和设计,用于治疗癌症幸存者的失眠。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Individuals with cancer are disproportionately affected by sleep disturbances, relative to the general population. These problems can be a consequence of the psychological, behavioral and physical effects of a cancer diagnosis and treatment. Sleep disturbances often persist for years and, when combined with already high levels of cancer-related distress, may place cancer survivors at a higher risk of future psychopathology, health problems and poorer quality of life. It is important to develop and evaluate treatments that comprehensively address the common symptom profiles experienced by cancer survivors. METHODS: This study is a randomized controlled non-inferiority trial comparing Cognitive Behavior Therapy for Insomnia (CBT-I; a known efficacious treatment) to Mindfulness-Based Stress Reduction (MBSR; a treatment with demonstrated potential). This design can efficiently compare these two treatments directly and determine whether MBSR performs to the same standard as CBT-I for the treatment of insomnia with additional benefits of reducing cancer-related distress. Participants are randomly assigned to an 8-week CBT-I or MBSR group. Sleep indices are measured using subjective (sleep diaries) and objective (actigraphy) assessment tools. The primary outcome is insomnia severity. Secondary outcomes include sleep quality, symptoms of stress, mood disturbance, mindfulness, and dysfunctional beliefs and attitudes toward sleep. Assessments are completed at three time periods: pre-treatment, post-treatment and at 3month follow up. CONCLUSIONS: Considering the high prevalence of distress and sleep disturbances in the cancer population, should MBSR produce sleep effects comparable to CBT-I, it may be more comprehensive - making it the treatment of choice for addressing cancer-related psychological sequelae.
机译:相对于普通人群,患有癌症的个体受睡眠障碍的影响尤其严重。这些问题可能是癌症诊断和治疗的心理,行为和身体影响的结果。睡眠障碍通常会持续数年,再加上已经与癌症相关的高度困扰,可能使癌症幸存者面临更高的未来心理病理风险,健康问题和较差的生活质量。重要的是开发和评估能够全面解决癌症幸存者所经历的常见症状特征的治疗方法。方法:本研究是一项随机对照的非劣效性试验,比较了失眠的认知行为疗法(CBT-1;一种已知的有效疗法)与基于正念减压的疗法(MBSR;一种具有潜在潜力的疗法)。该设计可以直接直接有效地比较这两种治疗方法,并确定MBSR在治疗失眠方面是否达到与CBT-1相同的标准,并具有减少癌症相关困扰的其他好处。参与者被随机分配到一个为期8周的CBT-1或MBSR组。使用主观(睡眠日记)和客观(书法)评估工具来测量睡眠指数。主要结果是失眠的严重程度。次要结果包括睡眠质量,压力症状,情绪紊乱,正念,机能障碍和对睡眠的态度。评估在三个时间段完成:治疗前,治疗后和三个月的随访。结论:考虑到癌症人群中困扰和睡眠障碍的高发生率,如果MBSR产生与CBT-I相当的睡眠效果,则可能更全面-使其成为解决与癌症相关的心理后遗症的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号